National Institute of Diabetes and Digestive and Kidney Diseases
IgA nephropathy is the third most common type of kidney disease. Learn about its causes, risk factors, and symptoms, as well as how it’s diagnosed and how it’s treated.
Your immune system produces the antibody Immunoglobulin A (IgA) to help fight off viruses and bacteria. Sometimes, though, these antibodies can form deposits that build up in the kidneys, cause inflammation, and harm your kidney tissue. When this occurs, the condition is called Immunoglobulin A nephropathy (IgAN), also known as Berger’s disease.
Experts think that IgAN is an autoimmune disease, which is when cells that are designed to protect your body start attacking it instead. People who have IgAN have a higher level of Immunoglobulin A (IgA) in their blood, which contains less of a type of sugar, called galactose.
The normal antibodies target the galactose-deficient antibodies as foreign; they respond by attaching to them in an attempt to neutralize them. The clumps that form when this occurs can get stuck in your kidneys’ filtering mechanism.
There may also be a genetic component to the disease’s development.
The structural and functional unit of your kidneys’ filtering system is called a nephron. Inside the nephron are glomeruli, or clusters of small, looping blood vessels that filter the blood to remove wastes and excess fluid.
When the IgA deposits build up in the glomeruli, they become weakened and inflamed, allowing blood and proteins to leak into your urine. Over time, scarring can occur in the nephron, which further damages the kidney and leads to kidney failure and dialysis.
Between 20 and 40% of adults progress to kidney failure, or end-stage kidney disease (ESKD), approximately 10 to 20 years after the onset of IgAN.
IgAN is the third most common type of kidney disease, after those caused by diabetes and hypertension, and it can occur to people of all ages, sexes, and races. Scientists have identified certain factors, however, that can increase your risk.
These risk factors include:
As with several other kidney diseases, IgAN may be asymptomatic in its early stages. Noticeable symptoms in later stages may include the following:
IgAN complications may include:
Most forms of kidney disease can generally be diagnosed with blood and urine tests, but an IgAN diagnosis requires a kidney biopsy. This type of biopsy is guided by an ultrasound or CAT scan, during which a small tissue sample is extracted from your kidney for further examination. The procedure may take place in a hospital or outpatient center. Like blood and urine tests, the biopsy is also able to indicate the degree of kidney function loss.
There is currently no cure for IgAN. Treatment is geared toward slowing the progression of the disease and delaying, or preventing, kidney failure.
The most common treatment methods include:
Medications to:
Lifestyle changes, such as:
Avoid making major changes on your own. Your doctor and dietician will help you craft a personalized diet plan to maximize safety and nutrition.
For more information, visit the IgA Nephropathy Foundation and National Kidney Foundation websites.
*National Institute of Diabetes and Digestive and Kidney Diseases. (2020, Nov. 9). IgA Nephropathy. https://www.niddk.nih.gov/health-information/kidney-disease/iga-nephropathy
Source: {{articlecontent.article.sourceName}}
Receive daily updated expert-reviewed article summaries. Everything you need to know from discoveries, treatments, and living tips!
Already a Responsum member?
Available for Apple iOS and Android
Add Comments
Cancel